Dendritic cell/tumor hybridoma vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Dendritic cell/tumor hybridoma vaccine, covering 2026-01-23 to 2026-01-23. Get the full timeline:
Most recent: Clinical Trial Update: The Use of Dendritic Cell/Tumor Hybridomas as a Novel Tumor Vaccine in Patients With Advance Melanoma [Phase 1, Phase 2]